Clinical trial · Observational
A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test
A Prospective Study of Clinical Outcomes for the Pathwork® Tissue of Origin Test
NCT01649453CI-TRIAL-00009658terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Terminated by sponsor.
Summary
Brief summary (as posted)
The study prospectively assesses the change in cancer-specific clinical decisions and outcomes before and after physicians received results from the Pathwork® Tissue of Origin (TOO) Test for patients whose primary site of cancer origin is uncertain.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasm Metastasis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pathwork® Tissue of Origin Test | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Cancer of uncertain primary
- interventionNames
- Device: Pathwork® Tissue of Origin Test
Primary outcomes (1)
- measure
- Survival
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * their physician ordered or intends to order a Pathwork® TOO Test between May 2012 and December 2013 * the patient is ≥ 18 years of age * the patient has given informed consent (online or verbal) * the patient is able to understand English.
References
Publications (0)
Data not yet available
No reference posted for this study.